US Patent 11420935 Bicyclic compounds
Patent 11420935 was granted and assigned to Vivace Therapeutics on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Dec, 2023
Megan Gustafson
Edits made to:
Infobox (+1/-1 properties)
Infobox
Current Assignee
00
Current Assignee
Megan Gustafson
Edits made to:
Infobox (+1/-1 properties)
Infobox
Patent Applicant
00
Patent Applicant
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
114209350
Date of Patent
August 23, 2022
0Patent Application Number
168497280
Date Filed
April 15, 2020
0Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
114209350
Date of Patent
August 23, 2022
0Patent Application Number
168497280
Date Filed
April 15, 2020
0Patent Primary Examiner
Edits on 24 Aug, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+276 characters)
US Patent 11420935 Bicyclic compounds
Article
Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating deseases, such as cancers. Specific cancers include those that are mediated by YAP/TAZ or those that are modulated by the interaction between YAP/TAZ and TEAD.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11420935
Date of Patent
August 23, 2022
Patent Application Number
16849728
Date Filed
April 15, 2020
Patent Primary Examiner
Find more entities like US Patent 11420935 Bicyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.